AGN needs to publish the CHDR DMT peer review, or/and, AGN needs to sell their IPF/CC trial results and Ifenprodil rights, these should get the phase 2 of the Microdose DMT / stroke trial started which is the real possible success story here. All investors in this speculative stock would be real happy for some good overdue news. Many would then show support with some further investments ...IMHFO... ...GLTA...